AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
The impact of oral anticoagulant therapy, factor VIII level and quality offactor V-deficient plasma on three commercial methods for activated protein C resistance
Authors: Chitolie, A Lawrie, AS Mackie, IJ Harrison, P Machin, SJ
Citation: A. Chitolie et al., The impact of oral anticoagulant therapy, factor VIII level and quality offactor V-deficient plasma on three commercial methods for activated protein C resistance, BL COAG FIB, 12(3), 2001, pp. 179-186
Plasma levels of factor XIIa and factor VIIa are increased but not relatedin primary hyperlipidaemia
Authors: Cardigan, RA Crook, M Mackie, IJ Machin, SJ
Citation: Ra. Cardigan et al., Plasma levels of factor XIIa and factor VIIa are increased but not relatedin primary hyperlipidaemia, BL COAG FIB, 12(3), 2001, pp. 187-192
Effect of lupus anticoagulants on INR with different thromboplastins
Authors: Lawrie, AS Mackie, IJ Purdy, G Machin, SJ
Citation: As. Lawrie et al., Effect of lupus anticoagulants on INR with different thromboplastins, BL COAG FIB, 12(3), 2001, pp. 221-221
Determination of plasma aprotinin levels by functional and immunologic assays
Authors: Cardigan, RA Mackie, IJ Gippner-Steppert, C Jochum, M Royston, D Gallimore, MJ
Citation: Ra. Cardigan et al., Determination of plasma aprotinin levels by functional and immunologic assays, BL COAG FIB, 12(1), 2001, pp. 37-42
Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial
Authors: Scurr, JH Machin, SJ Bailey-King, S Mackie, IJ McDonald, S Smith, PDC
Citation: Jh. Scurr et al., Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial, LANCET, 357(9267), 2001, pp. 1485-1489
Increased circulating platelet-leucocyte complexes and platelet activationin patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis
Authors: Joseph, JE Harrison, P Mackie, IJ Isenberg, DA Machin, SJ
Citation: Je. Joseph et al., Increased circulating platelet-leucocyte complexes and platelet activationin patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis, BR J HAEM, 115(2), 2001, pp. 451-459
Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome
Authors: Adams, MJ Donohoe, S Mackie, IJ Machin, SJ
Citation: Mj. Adams et al., Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome, BR J HAEM, 114(2), 2001, pp. 375-379
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over
Authors: Mackie, IJ Piegsa, K Furs, SA Johnson, J Bounds, W Machin, SJ Guillebaud, J
Citation: Ij. Mackie et al., Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over, BR J HAEM, 113(4), 2001, pp. 898-904
Anti-prothrombin antibodies: assay conditions and clinical associations inthe anti-phospholipid syndrome
Authors: Donohoe, S Mackie, IJ Isenberg, D Machin, SJ
Citation: S. Donohoe et al., Anti-prothrombin antibodies: assay conditions and clinical associations inthe anti-phospholipid syndrome, BR J HAEM, 113(2), 2001, pp. 544-549
Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome
Authors: Jones, DW Mackie, IJ Gallimore, MJ Winter, M
Citation: Dw. Jones et al., Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome, BR J HAEM, 113(2), 2001, pp. 550-552
Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies
Authors: Donohoe, S Kingdom, JCP Mackie, IJ Burrell, S Quenby, S Jauniaux, E Machin, SJ
Citation: S. Donohoe et al., Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies, THROMB HAEM, 84(1), 2000, pp. 32-38
Effect of instruments on lupus anticoagulant testing - Rebuttal
Authors: Lawrie, AS Mackie, IJ Purdy, G Machin, SJ
Citation: As. Lawrie et al., Effect of instruments on lupus anticoagulant testing - Rebuttal, THROMB HAEM, 83(2), 2000, pp. 346-348
Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin
Authors: Wittke, B Ensor, H Chung, J Birnbock, H Lausecker, B Ertel, SI Mackie, IJ Machin, SJ
Citation: B. Wittke et al., Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin, BR J CL PH, 49(3), 2000, pp. 231-239
Two colour analysis of reticulated platelets
Authors: Robinson, MSC Mackie, IJ Machin, SJ Harrison, P
Citation: Msc. Robinson et al., Two colour analysis of reticulated platelets, CLIN LAB H, 22(4), 2000, pp. 211-213
von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura
Authors: Allford, SL Harrison, P Lawrie, AS Liesner, R Mackie, IJ Machin, SJ
Citation: Sl. Allford et al., von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura, BR J HAEM, 111(4), 2000, pp. 1215-1222
The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
Authors: Gardiner, C Mackie, IJ Malia, RG Jones, DW Winter, M Leeming, D Taberner, DA Machin, SJ Greaves, M
Citation: C. Gardiner et al., The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant, BR J HAEM, 111(4), 2000, pp. 1230-1235
Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII
Authors: Jones, DW Gallimore, MJ Mackie, IJ Harris, SL Winter, M
Citation: Dw. Jones et al., Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII, BR J HAEM, 110(3), 2000, pp. 721-726
Lupus anticoagulant measurement
Authors: Mackie, IJ Donohoe, S Machin, SJ
Citation: Ij. Mackie et al., Lupus anticoagulant measurement, HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, 2000, pp. 214-224
Affinity purified human antiphospholipid antibodies bind normal term placenta
Authors: Donohoe, S Kingdom, JCP Mackie, IJ
Citation: S. Donohoe et al., Affinity purified human antiphospholipid antibodies bind normal term placenta, LUPUS, 8(7), 1999, pp. 525-531
Maternal cardiolipin, beta(2)-glycoprotein-I and prothrombin antibody expression in high-risk pregnancies with bilateral abnormal uterine artery Doppler waveforms
Authors: Donohoe, S Geary, M Kingdom, JCP Jauniaux, E Purdy, G Mackie, IJ
Citation: S. Donohoe et al., Maternal cardiolipin, beta(2)-glycoprotein-I and prothrombin antibody expression in high-risk pregnancies with bilateral abnormal uterine artery Doppler waveforms, ULTRASOUN O, 13(5), 1999, pp. 317-322
Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis
Authors: Harrison, P Robinson, MSC Mackie, IJ Joseph, J McDonald, SJ Liesner, R Savidge, GF Pasi, J Machin, SJ
Citation: P. Harrison et al., Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis, BL COAG FIB, 10(1), 1999, pp. 25-31
The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers
Authors: Lawrie, AS Mackie, IJ Purdy, G Machin, SJ
Citation: As. Lawrie et al., The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers, THROMB HAEM, 81(5), 1999, pp. 758-762
Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascendingoral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers
Authors: Wittke, B Mackie, IJ Machin, SJ Timm, U Zell, M Goggin, T
Citation: B. Wittke et al., Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascendingoral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers, BR J CL PH, 47(5), 1999, pp. 521-530
Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration
Authors: Cardigan, RA McGloin, H Mackie, IJ Machin, SJ Singer, M
Citation: Ra. Cardigan et al., Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration, KIDNEY INT, 55(4), 1999, pp. 1568-1574
Patterns of drowning in Australia, 1992-1997
Authors: Mackie, IJ
Citation: Ij. Mackie, Patterns of drowning in Australia, 1992-1997, MED J AUST, 171(11-12), 1999, pp. 587-590
Risultati: 1-25 | 26-26